These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 6108607

  • 21. Comparison of famotidine 40 mg with ranitidine 300 mg at night in short-term duodenal ulcer healing. A South African multicentre study.
    Marks IN, Wright JP.
    S Afr Med J; 1987 Jul 04; 72(1):18-20. PubMed ID: 2885928
    [Abstract] [Full Text] [Related]

  • 22. [Multi-center double-blind clinical trial of ranitidine in the treatment of stomach and duodenal ulcers].
    Gibiński K, Nowak A, Gabrylewicz A, Laszewicz W, Hasik J, Klincewicz H, Pokora J, Czarnecki J, Kosecki J, Pachlewski J.
    Pol Arch Med Wewn; 1982 Jul 04; 68(3):117-24. PubMed ID: 6133269
    [No Abstract] [Full Text] [Related]

  • 23. Clinical and endocrine aspects of treatment with ranitidine.
    Boyd EJ, Peden NR, Browning MC, Saunders JH, Wormsley KG.
    Scand J Gastroenterol Suppl; 1981 Jun 04; 69():81-3. PubMed ID: 6119787
    [Abstract] [Full Text] [Related]

  • 24. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
    Hüttemann W.
    Drugs; 1988 Jun 04; 35 Suppl 3():90-5. PubMed ID: 2905255
    [Abstract] [Full Text] [Related]

  • 25. [Ranitidine, a newly developed histamine H2-receptor antagonist. First experimental and clinical results].
    Simon B, Dammann HG, Müller P, Kather H.
    Dtsch Med Wochenschr; 1980 Dec 12; 105(50):1753-5. PubMed ID: 6108203
    [No Abstract] [Full Text] [Related]

  • 26. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
    Gibinski K, Nowak A, Gabryelewicz A, Szalaj W, Hasik J, Klincewicz H, Pokora J, Radwan P, Kosecki P, Pachlewski J.
    Dtsch Z Verdau Stoffwechselkr; 1982 Dec 12; 42(2-3):64-9. PubMed ID: 6286274
    [Abstract] [Full Text] [Related]

  • 27. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
    Simon B, Cremer M, Dammann HG, Hentschel E, Keohane PP, Mulder H, Müller P, Sarles H.
    Scand J Gastroenterol Suppl; 1987 Dec 12; 136():61-70. PubMed ID: 2892257
    [Abstract] [Full Text] [Related]

  • 28. Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients.
    Konturek SJ, Obtułowicz W, Kwiecień N, Sito E, Oleksy J, Miszczuk-Jamska B.
    Dig Dis Sci; 1980 Oct 12; 25(10):737-43. PubMed ID: 6107221
    [Abstract] [Full Text] [Related]

  • 29. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
    Korman MG, Hansky J, Eaves ER, Schmidt GT.
    Gastroenterology; 1983 Oct 12; 85(4):871-4. PubMed ID: 6136450
    [Abstract] [Full Text] [Related]

  • 30. Treatment of gastric ulcer with ranitidine.
    Schulz TB, Berstad A, Rydning A, Frislid K.
    Scand J Gastroenterol; 1984 Jan 12; 19(1):119-21. PubMed ID: 6324332
    [Abstract] [Full Text] [Related]

  • 31. Roxatidine versus ranitidine in the treatment of duodenal ulcers: a randomized double-blind controlled multicentre study in Singapore.
    Fock KM, Kang JY, Ng HS, Ng TM, Gwee KA, Lim CC.
    J Gastroenterol Hepatol; 1995 Jan 12; 10(4):379-82. PubMed ID: 8527701
    [Abstract] [Full Text] [Related]

  • 32. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
    Simon B, Dammann HG, Jakob G, Miederer SE, Müller P, Ottenjann R, Paul F, Scholten T, Schütz E, Seifert E.
    Digestion; 1985 Jan 12; 32 Suppl 1():32-7. PubMed ID: 2866134
    [Abstract] [Full Text] [Related]

  • 33. [Ranitidine in the treatment of duodenal ulcer. Initial clinical experience with 33 patients].
    Noya G, Dettori G, Antona C, Niolu P, Muscas A, Marongiu G, Biglioli P.
    Minerva Med; 1983 Mar 31; 74(13):691-3. PubMed ID: 6132353
    [Abstract] [Full Text] [Related]

  • 34. Healing of gastric ulcers after one, two, and three months of ranitidine.
    Ashton MG, Holdsworth CD, Ryan FP, Moore M.
    Br Med J (Clin Res Ed); 1982 Feb 13; 284(6314):467-8. PubMed ID: 6120738
    [Abstract] [Full Text] [Related]

  • 35. Ranitidine in the treatment of duodenal ulceration.
    Peden NR, Boyd EJ, Saunders JH, Wormsley KG.
    Scand J Gastroenterol; 1981 Apr 13; 16(3):325-9. PubMed ID: 16435471
    [Abstract] [Full Text] [Related]

  • 36. Ranitidine in the treatment of duodenal and prepyloric ulcer: comparison of two dosage regimens.
    Brunner H, Pesendorfer FX, Pötzi R.
    J Int Med Res; 1983 Apr 13; 11(3):167-72. PubMed ID: 6307772
    [Abstract] [Full Text] [Related]

  • 37. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
    Matov V, Metchkov G, Krastev Z, Tchernev K, Mitova R, Márquez M, Torres J, Herrero E, Fillat O, Ortiz JA.
    Arzneimittelforschung; 1997 Apr 13; 47(4A):555-9. PubMed ID: 9205764
    [Abstract] [Full Text] [Related]

  • 38. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
    Sevvel S, Ananthakrishnan N, Kate V.
    Trop Gastroenterol; 1996 Apr 13; 17(4):227-9. PubMed ID: 9094865
    [Abstract] [Full Text] [Related]

  • 39. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD, Naesdal J, Bianchi Porro G, Petrillo M, Lazzaroni M, Hinchliffe RF, Thompson M, Morris P, Daly MJ, Carroll NJ.
    Gut; 1991 Apr 13; 32(4):435-8. PubMed ID: 1673953
    [Abstract] [Full Text] [Related]

  • 40. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
    Darle N, Almskog B, Falk A, Fredriksen B, Gamklou R, Ivarsson L, Karlström L.
    Ann Clin Res; 1984 Apr 13; 16(1):6-9. PubMed ID: 6331270
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.